CKD Bio Corp operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CKD Bio Corp with three other
companies in this sector in South Korea:
Hwail Pharmaceutical Company Limited
sales of 106.13 billion Korean Won [US$90.32 million]
Kolon Life Science Incorporation
(121.18 billion Korean Won [US$103.12 million]
of which 42%
was Pharmaceutical Business), and
Ctc Bio, Incorporation.
(118.99 billion Korean Won [US$101.26 million]
CKD Bio Corp reported sales of 106.69 billion Korean Won (US$90.79 million)
December of 2015.
a very small
increase of 0.3%
versus 2014, when the company's sales were 106.39 billion Korean Won.